-transparent.png){kind=logo}
In the present study we characterize key activities of an agent designed to simultaneously inhibit angiotensin I-converting enzyme (ACE) and neutral endopeptidase (NEP). MDL 100,240 is a thioester prodrug of MDL 100,173, which is a potent competitive inhibitor of both ACE and NEP in vitro. MDL 100,240 was shown in an ex vivo study to inhibit both of these enzymes in rat kidney. When administered to anesthetized rats, MDL 100,240 enhanced the effect of infused ANP on blood pressure, diuresis and natriuresis and of infused bradykinin on blood pressure. Moreover, MDL 100,173 and MDL 100,240 inhibited the pressor response to angiotensin I. These results indicate that MDL 100,173 and its prodrug, MDL 100,240, produced effects, in vivo, consistent with inhibition of both ACE and NEP.
J F French, and
G A Flynn, and
E L Giroux, and
S Mehdi, and
B Anderson, and
D C Beach, and
J R Koehl, and
R C Dage
May 1987,
Kidney international. Supplement,
J F French, and
G A Flynn, and
E L Giroux, and
S Mehdi, and
B Anderson, and
D C Beach, and
J R Koehl, and
R C Dage
January 2001,
Heart disease (Hagerstown, Md.),
J F French, and
G A Flynn, and
E L Giroux, and
S Mehdi, and
B Anderson, and
D C Beach, and
J R Koehl, and
R C Dage
January 2005,
Cardiovascular drug reviews,
J F French, and
G A Flynn, and
E L Giroux, and
S Mehdi, and
B Anderson, and
D C Beach, and
J R Koehl, and
R C Dage
November 1996,
Journal of cardiovascular pharmacology,
J F French, and
G A Flynn, and
E L Giroux, and
S Mehdi, and
B Anderson, and
D C Beach, and
J R Koehl, and
R C Dage
April 1999,
Clinical pharmacology and therapeutics,
J F French, and
G A Flynn, and
E L Giroux, and
S Mehdi, and
B Anderson, and
D C Beach, and
J R Koehl, and
R C Dage
April 2004,
Journal of clinical pharmacology,
J F French, and
G A Flynn, and
E L Giroux, and
S Mehdi, and
B Anderson, and
D C Beach, and
J R Koehl, and
R C Dage
December 2004,
Journal of clinical pharmacology,
J F French, and
G A Flynn, and
E L Giroux, and
S Mehdi, and
B Anderson, and
D C Beach, and
J R Koehl, and
R C Dage
March 1998,
The Journal of pharmacology and experimental therapeutics,
J F French, and
G A Flynn, and
E L Giroux, and
S Mehdi, and
B Anderson, and
D C Beach, and
J R Koehl, and
R C Dage
June 1999,
American journal of hypertension,
J F French, and
G A Flynn, and
E L Giroux, and
S Mehdi, and
B Anderson, and
D C Beach, and
J R Koehl, and
R C Dage
December 1995,
Journal of medicinal chemistry,
